Can-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602

Patent has already been issued in other major markets including the U.S.

...

Related Keywords

United States ,Israel ,American ,Motti Farbstein ,Fite Biopharma Ltd ,European Patent Office ,Drug Administration ,Market Research ,Can Fite Biopharma ,Receptor Ligands For Use ,Erectile Dysfunction ,Fite Biopharma ,Orphan Drug Designation ,Fast Track Designation ,Annual Report ,Markets ,